A randomized controlled trial to evaluate laparoscopic versus open complete mesocolic excision (CME) for stage II, III colorectal cancer (CRC): First efficacy results from Japan Clinical Oncology Group Study JCOG0404.

被引：4

作者：

Inomata, Masafumi

Katayama, Hiroshi

Mizusawa, Junki

Watanabe, Masahiko

Sugihara, Kenichi

Konishi, Fumio

Yamamoto, Seiichiro

Saito, Shuji

Fujii, Shoichi

Saida, Yoshihisa

Hasegawa, Hirotoshi

Etoh, Tsuyoshi

Moriya, Yoshihiro

Kitano, Seigo

机构：

[1] Oita Univ, Fac Med, Dept Gastroenterol & Pediat Surg, Oita 87011, Japan

[2] Natl Canc Ctr, JCOG Operat Off, Tokyo 104, Japan

[3] Natl Canc Ctr, JCOG Data Ctr, Tokyo 104, Japan

[4] Kitasato Univ, Sch Med, Sagamihara, Kanagawa 228, Japan

[5] Tokyo Med & Dent Univ, Grad Sch, Dept Surg Oncol, Tokyo, Japan

[6] Nerima Hikarigtaoka Hosp, Dept Surg, Tokyo, Japan

[7] Natl Canc Ctr, Div Colorectal Surg, Tokyo 104, Japan

[8] Shizuoka Canc Ctr, Dept Colon & Rectal Surg, Shizuoka, Japan

[9] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa 232, Japan

[10] Toho Univ, Ohashi Hosp, Tokyo, Japan

[11] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan

[12] Oita Univ, Fac Med, Oita 87011, Japan

[13] Natl Canc Ctr, Tokyo, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期

关键词：

D O I：

10.1200/jco.2015.33.3_suppl.656

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

656

引用

页数：1

共 50 条

[41] Randomized phase III study of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients (pts) with stage III colon cancer (CC): Final results of Japan Clinical Oncology Group study (JCOG0205)
Shimada, Yasuhiro
Hamaguchi, Tetsuya
Moriya, Yoshihiro
Saito, Norio
Kanemitsu, Yukihide
Takiguchi, Nobuhiro
Ohue, Masayuki
Kato, Takeshi
Takii, Yasumasa
Sato, Toshihiko
Tomita, Naohiro
Yamaguchi, Shigeki
Akaike, Makoto
Mishima, Hideyuki
Kubo, Yoshiro
Mizusawa, Junki
Nakamura, Kenichi
Fukuda, Haruhiko
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[42] Randomized phase II trial of gemcitabine plus S-1 combination therapy versus S-1 in advanced biliary tract cancer: Results of the Japan Clinical Oncology Group study (JCOG0805)
Morizane, Chigusa
Okusaka, Takuji
Mizusawa, Junki
Takashima, Atsuo
Ueno, Makoto
Ikeda, Masafumi
Hamamoto, Yasuo
Ishii, Hiroshi
Boku, Narikazu
Furuse, Junji
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
[43] RANDOMIZED PHASE II TRIAL OF GEMCITABINE PLUS S-1 COMBINATION THERAPY VERSUS S-1 IN ADVANCED BILIARY TRACT CANCER: RESULTS OF THE JAPAN CLINICAL ONCOLOGY GROUP STUDY (JCOG0805)
Ikeda, M.
Okusaka, T.
Mizusawa, J.
Takashima, A.
Morizane, C.
Ueno, M.
Hamamoto, Y.
Ishii, H.
Hara, H.
Fukutomi, A.
Furukawa, M.
Nagase, M.
Yamaguchi, T.
Boku, N.
Furuse, J.
ANNALS OF ONCOLOGY, 2012, 23 : 15 - 15
[44] A phase III randomized controlled trial comparing surgery plus adjuvant chemotherapy with or without preoperative chemoradiotherapy for locally recurrent rectal cancer: A Japan Clinical Oncology Group study (JCOG1801)
Tsukada, Yuichiro
Ito, Masaaki
Nakamura, Naoki
Ito, Yoshinori
Bando, Hideaki
Ando, Masahiko
Onaya, Hiroaki
Ikeda, Masataka
Sekimoto, Mitsugu
Kadota, Tomohiro
Katayama, Hiroshi
Mizusawa, Junki
Fukuda, Haruhiko
Kanemitsu, Yukihide
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[45] Randomized phase II trial of gemcitabine plus S-1 combination therapy versus S-1 in advanced biliary tract cancer: Results of the Japan Clinical Oncology Group study (JCOG0805)
Ueno, Makoto
Okusaka, Takuji
Mizusawa, Junki
Takashima, Atsuo
Morizane, Chigusa
Ikeda, Masafumi
Hamamoto, Yasuo
Ishii, Hiroshi
Hara, Hiroki
Fukutomi, Akira
Furukawa, Masayuki
Nagase, Michitaka
Yamaguchi, Taketo
Yamao, Kenji
Nakamori, Shoji
Ioka, Tatsuya
Iguchi, Haruo
Miyakawa, Hiroyuki
Boku, Narikazu
Furuse, Junji
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[46] A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Japan Clinical Oncology Group study JCOG2202 (LAPAN study)
Naoki Ikenaga
Tadayoshi Hashimoto
Junki Mizusawa
Ryo Kitabayashi
Yusuke Sano
Haruhiko Fukuda
Kohei Nakata
Kazuto Shibuya
Yuji Kitahata
Minoru Takada
Keiko Kamei
Hiroshi Kurahara
Daisuke Ban
Shogo Kobayashi
Hiroaki Nagano
Hajime Imamura
Michiaki Unno
Amane Takahashi
Shintaro Yagi
Hiroshi Wada
Hirofumi Shirakawa
Naoto Yamamoto
Seiko Hirono
Naoto Gotohda
Etsuro Hatano
Masafumi Nakamura
Makoto Ueno
BMC Cancer, 24
[47] A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Japan Clinical Oncology Group study JCOG2202 (LAPAN study)
Ikenaga, Naoki
Hashimoto, Tadayoshi
Mizusawa, Junki
Kitabayashi, Ryo
Sano, Yusuke
Fukuda, Haruhiko
Nakata, Kohei
Shibuya, Kazuto
Kitahata, Yuji
Takada, Minoru
Kamei, Keiko
Kurahara, Hiroshi
Ban, Daisuke
Kobayashi, Shogo
Nagano, Hiroaki
Imamura, Hajime
Unno, Michiaki
Takahashi, Amane
Yagi, Shintaro
Wada, Hiroshi
Shirakawa, Hirofumi
Yamamoto, Naoto
Hirono, Seiko
Gotohda, Naoto
Hatano, Etsuro
Nakamura, Masafumi
Ueno, Makoto
BMC CANCER, 2024, 24 (01)
[48] Mesorectal excision with or without lateral lymph node dissection for clinical stage II, III lower rectal cancer: Long-term follow-up data of Japan Clinical Oncology Group study JCOG0212.
Ota, Mitsuyoshi
Fujita, Shin
Mizusawa, Junki
Kanemitsu, Yukihide
Ito, Masaaki
Shiomi, Akio
Ohue, Masayuki
Fujii, Shoichi
Saito, Shuji
Shiozawa, Manabu
Yamaguchi, Takashi
Bando, Hiroyuki
Katsumata, Kenji
Okamura, Shu
Akagi, Yoshito
Takiguchi, Nobuhiro
Yamaguchi, Shigeki
Ike, Hideyuki
Akasu, Takayuki
Moriya, Yoshihiro
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[49] Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-2N0-2 gastric cancer patients: Japan Clinical Oncology Group study JCOG1907 (MONA LISA study).
Makuuchi, Rie
Terada, Mitsumi
Mizusawa, Junki
Tokunaga, Masanori
Hosoda, Kei
Ojima, Toshiyasu
Omori, Takeshi
Ehara, Kazuhisa
Watanabe, Masaya
Takagane, Akinori
Nishida, Yasunori
Yanagimoto, Yoshitomo
Boku, Narikazu
Yoshikawa, Takaki
Terashima, Masanori
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
[50] Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205)
Ohtsu, A
Shimada, Y
Shirao, K
Boku, N
Hyodo, I
Saito, H
Yamamichi, N
Miyata, Y
Ikeda, N
Yamamoto, S
Fukuda, H
Yoshida, S
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 54 - 59

← 1 2 3 4 5 →